In vivo recellularization of decellularized vascular scaffolds cross-linked with anti-CD34 antibody
10.3724/SP.J.1008.2010.00369
- Author:
Man-Jing ZHANG
1
Author Information
1. Division of Plastic Surgery
- Publication Type:Journal Article
- Keywords:
Anti-CD34 antibodies;
Cross-link reagents;
Decellularized vascular scaffolds;
Vascular endothelium
- From:
Academic Journal of Second Military Medical University
2010;31(4):369-373
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the role of decellularized vascular scaffolds coated with anti-CD34 antibodies in capturing endothelial progenitor cells from the circulation to participate in recellularization. Methods: Fresh caprine forelimb arteries were treated with repeated frozen/thawing, ultrahigh pressure and SDS to prepare decellularized vascular scaffolds. After reaction with photochemical crosslinker SANPAH, anti-rabbit CD34 was coated onto the decellularized vascular scaffolds using ultraviolet ray. Twenty New Zealand white rabbits were performed for right lower-abdominal pedicled skin flap, which were supplied by branches of femoral artery. Whole defects (1 cm) were made in femoral arteries and end-to-end anastomosis repaired by 10 cross-linked and 10 non-cross-linked scaffolds in experimental group and control group, respectively. The patency of the pedicle was observed through color and appearance of the flap postoperatively. After transplantation, patency rate and cell seeding were detected by Doppler, DSA, and pathological test. Results:. Flaps of the experimental group had good blood supply after transplantation, while swelling and necrosis could be found in the control group. Doppler and DSA showed that the 7 of 10 cross-linked scaffolds remained patent for 4 weeks and there was no stenonsis, but all the scaffolds were obstructed in the control group after 1 week. Hematoxylin and eosin staining revealed that the inner layers of cross-linked scaffolds were partly covered with endothelial cells four weeks later, and there was no noticeable stenosis. In contrast, thrombosis formation was noticed in the control group and there was no cell coverage one week after operation. Conclusion: Cross-linked scaffolds with anti-CD34 antibodies are superior to bare scaffolds in early postoperative anticoagulation and patency.
